ARTICLE | Clinical News
Smart Anti-L-Selectin antibody: Began Phase Ib trial
November 12, 2001 8:00 AM UTC
Protein Design Labs Inc. (PDLI), Fremont, Calif. Product: Smart Anti-L-Selectin antibody Business: Autoimmune/Inflammation Therapeutic category: Antibody, Immune modulation Target: Endothelial cells l...